INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845P908. A total of 5 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,761,300 | +28.3% | 95,000 | -23.4% | 0.01% | +50.0% |
| Q2 2023 | $1,372,546 | +42.5% | 124,100 | +73.1% | 0.00% | +33.3% |
| Q1 2023 | $962,931 | -68.4% | 71,700 | -70.9% | 0.00% | -57.1% |
| Q4 2022 | $3,044,257 | -32.8% | 246,100 | -24.2% | 0.01% | -22.2% |
| Q3 2022 | $4,530,000 | +12.1% | 324,700 | +11.0% | 0.01% | +50.0% |
| Q2 2022 | $4,041,000 | +131.0% | 292,600 | +172.2% | 0.01% | +200.0% |
| Q1 2022 | $1,749,000 | -45.2% | 107,500 | -45.1% | 0.00% | -33.3% |
| Q4 2021 | $3,190,000 | +37.7% | 195,800 | +25.5% | 0.00% | 0.0% |
| Q3 2021 | $2,317,000 | +26.5% | 156,000 | +70.1% | 0.00% | +50.0% |
| Q2 2021 | $1,831,000 | +26.1% | 91,700 | +45.8% | 0.00% | 0.0% |
| Q1 2021 | $1,452,000 | -61.9% | 62,900 | -59.2% | 0.00% | -71.4% |
| Q4 2020 | $3,811,000 | -14.6% | 154,300 | +43.3% | 0.01% | -50.0% |
| Q3 2020 | $4,465,000 | -14.9% | 107,700 | -1.6% | 0.01% | -41.7% |
| Q2 2020 | $5,246,000 | -24.8% | 109,500 | -1.2% | 0.02% | -57.9% |
| Q1 2020 | $6,976,000 | -71.3% | 110,800 | -43.6% | 0.06% | -65.7% |
| Q4 2019 | $24,326,000 | +247.8% | 196,300 | +86.2% | 0.17% | +196.4% |
| Q3 2019 | $6,994,000 | -22.8% | 105,400 | -7.5% | 0.06% | -31.7% |
| Q2 2019 | $9,063,000 | -50.2% | 113,900 | -30.0% | 0.08% | -59.6% |
| Q1 2019 | $18,188,000 | +198.8% | 162,600 | +169.2% | 0.20% | +283.0% |
| Q4 2018 | $6,088,000 | -6.6% | 60,400 | +17.1% | 0.05% | +1.9% |
| Q3 2018 | $6,520,000 | +401.2% | 51,600 | +232.9% | 0.05% | +372.7% |
| Q2 2018 | $1,301,000 | +164.4% | 15,500 | +93.8% | 0.01% | +120.0% |
| Q1 2018 | $492,000 | -90.9% | 8,000 | -91.4% | 0.01% | -86.8% |
| Q4 2017 | $5,416,000 | -24.4% | 92,700 | -24.9% | 0.04% | -41.5% |
| Q3 2017 | $7,168,000 | +996.0% | 123,500 | +2187.0% | 0.06% | +828.6% |
| Q2 2017 | $654,000 | -19.7% | 5,400 | -25.0% | 0.01% | -22.2% |
| Q1 2017 | $814,000 | -51.0% | 7,200 | -52.9% | 0.01% | -43.8% |
| Q4 2016 | $1,662,000 | +405.2% | 15,300 | +665.0% | 0.02% | +300.0% |
| Q3 2016 | $329,000 | -58.8% | 2,000 | -64.3% | 0.00% | -55.6% |
| Q2 2016 | $799,000 | -25.0% | 5,600 | -32.5% | 0.01% | -40.0% |
| Q1 2016 | $1,066,000 | +346.0% | 8,300 | +418.8% | 0.02% | +400.0% |
| Q4 2015 | $239,000 | -39.9% | 1,600 | -33.3% | 0.00% | -50.0% |
| Q3 2015 | $398,000 | +106.2% | 2,400 | +200.0% | 0.01% | +100.0% |
| Q2 2015 | $193,000 | -96.0% | 800 | -95.4% | 0.00% | -96.1% |
| Q1 2015 | $4,879,000 | +565.6% | 17,300 | +268.1% | 0.08% | +600.0% |
| Q4 2014 | $733,000 | +521.2% | 4,700 | +840.0% | 0.01% | +450.0% |
| Q3 2014 | $118,000 | -44.6% | 500 | -44.4% | 0.00% | -33.3% |
| Q2 2014 | $213,000 | -94.7% | 900 | -92.7% | 0.00% | -95.6% |
| Q1 2014 | $4,056,000 | – | 12,300 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 71,700 | $962,931 | 0.00% |
| JANE STREET GROUP, LLC | 104,000 | $1,396,720 | 0.00% |
| SIMPLEX TRADING, LLC | 58,400 | $784 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |